SM
Sarah A. Morrow
Multiple sclerosisMultiple SclerosisCognitionCognitive Dysfunctionmultiple sclerosisCognitive impairmentDepressionNeuromyelitis OpticacognitionMultiple Sclerosis, Relapsing-Remitting
On Valency
published · living versionsW_894d8afa·v1 · currentpublished
Longitudinal tracking of multiple sclerosis lesions in the spinal cord: A validation study
with Pierre-Louis Benveniste, Julian McGinnis, Shannon Kolind, Larry D. Lynd +9
1 version
Preprints & journals
174 papers in the corpus · 2004–2026VEP latency delays predicts MRI neurodegenerative outcomes in multiple sclerosis.42788996 · Jakimovski, Dejan, Weller, Joanna, Zivadinov, Robert et al.2026 · 0 citationsJournal of neurology. 2026;273(10)
Mixed-amphetamine salts, extended release for cognitive impairment in persons with MS, a randomized controlled trial.42800227 · Morrow, Sarah A, Rosehart, Heather, Smyth, Penelope et al.2026 · 0 citationsMultiple sclerosis and related disorders. 2026;115:107932
Optimizing the management of AQP4 antibody-positive NMOSD: A Canadian consensus.42815166 · Rotstein, Dalia L, Beauchemin, Philippe, Burton, Jodie M et al.2026 · 0 citationsMultiple sclerosis and related disorders. 2026;115:107936
Longitudinal tracking of multiple sclerosis lesions in the spinal cord: A validation study2609.09424v1 · Pierre-Louis Benveniste, Julian McGinnis, Shannon Kolind et al.2026 · 0 citationsarXivon Valency
Multiple sclerosis and fear of falling: A complex interaction between cognitive network function and EDSS.42691809 · Dhakal, Bishal, Covey, Thomas J, Peterson, Daniel S et al.2026 · 0 citationsMultiple sclerosis and related disorders. 2026;115:107880
Risks and Benefits of Disease-Modifying Therapies in People Aging With Multiple Sclerosis.42921612 · Corboy, John R, Morrow, Sarah A, Bobryk, Patty et al.2026 · 0 citationsInternational journal of MS care. 2025;27(Suppl 2):T76-T82
Increased subpial cortical lesion detection at 3 tesla using Inversion Recovery Susceptibility Weighted Imaging with Enhanced T2 Weighting (IR-SWIET).42845575 · Sizer, Edward, Onyemeh, Kamso, Kohli, Amit et al.2026 · 0 citationsmedRxiv : the preprint server for health sciences. 2026
Aging and Multiple Sclerosis: Multidisciplinary Care and Access to Care.42921618 · Stewart, Renee, Stacom, Rachael, Bainbridge, Jacquelyn et al.2026 · 0 citationsInternational journal of MS care. 2025;27(Suppl 2):T70-T75
Invisible symptoms in multiple sclerosis and their impact on social role participation: A multidimensional analysis.42397840 · Bergmann, Catherine, Jackson, Daija, Nicholson, Rachel et al.2026 · 0 citationsMultiple sclerosis (Houndmills, Basingstoke, England). 2026:13524585261459835
Comorbidity, Polypharmacy, and Aging in Multiple Sclerosis.42921332 · Marrie, Ruth Ann, Bainbridge, Jacquelyn, Bobryk, Patty et al.2026 · 0 citationsInternational journal of MS care. 2025;27(Suppl 2):T59-T69
A pilot, single-arm feasibility study of a multidimensional behavioral intervention for cognitive fatigability in multiple sclerosis: Mental Energy Boost program.42256558 · Islam, Tamanna, Berard, Jason A, Ryan, Abby et al.2026 · 0 citationsFrontiers in neurology. 2026;17:1823950
Word finding difficulties in multiple sclerosis and its relation to cognitive impairment, fatigue and depression.42155383 · Tan, Mildred, Bogaardt, Hans, Barrera, Marissa A et al.2026 · 0 citationsMultiple sclerosis and related disorders. 2026;111:107259
Age-Related Changes in Multiple Sclerosis Pathophysiology and Clinical Function.42921589 · Zhang, Yinan, Bobryk, Patty, Morrow, Sarah A et al.2026 · 0 citationsInternational journal of MS care. 2025;27(Suppl 2):T53-T58
Myelin damage in radiologically isolated syndrome is associated with decreased processing speed.42153200 · Kalau, Olivia, Johnson, Poljanka, Oh, Jiwon et al.2026 · 0 citationsMultiple sclerosis journal - experimental, translational and clinical. 2026;12(2):20552173261446217
Discrepancy between subjective and objective cognitive function in multiple sclerosis and association with mood, fatigue, and pain.42145652 · Farah, Nour, Charbonneau, Simon, Morrow, Sarah A et al.2026 · 2 citationsMultiple sclerosis journal - experimental, translational and clinical. 2026;12(2):20552173261449673
Patient reported outcomes in NMOSD reflect a high disease burden and do not correlate with the EDSS.42116255 · Saeedzadeh, Elisa, Vyas, Manav V, Sharma, Shristi et al.2026 · 2 citationsMultiple sclerosis and related disorders. 2026;111:107223
Using cognitive testing to predict employment status in multiple sclerosis: A comparative study of the SDMT and a computerized cognitive assessment tool.41713333 · Jackson, Daija A, Bergmann, Catherine S, Wilken, Jeffrey et al.2026 · 0 citationsMultiple sclerosis and related disorders. 2026;108:107069
Demographic and Clinical Characteristics of Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder in Canadian Adults.41612764 · Momen, Amirah I, Freedman, Mark S, Fadda, Giulia et al.2026 · 1 citationThe Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2026:1-9
Periventricular gradients in axonal and myelin microstructure are present in people with multiple sclerosis having low and high disability.41454687 · Bernstein, Hannah R, Grouza, Vladimir, Gati, Joseph S et al.2026 · 1 citationMultiple sclerosis (Houndmills, Basingstoke, England). 2026;32(1):80-92
Lesion-Independent Associations Between Thalamic Nuclei Volumes and Information Processing Speed in Multiple Sclerosis2511.21677v3 · Arshya Pooladi-Darvish, Heather Rosehart, Marina R. Everest et al.2025 · 0 citationsarXiv
The Language and Memory Test: Multinational Feasibility Study of a Digital Test to Measure Cognitive Change.41251293 · Leavitt, Victoria M, Simani, Leila, Koch, Marcus W et al.2025 · 1 citationThe European journal of neuroscience. 2025;62(10):e70288
Letter From the Guest Editors - Multiple Sclerosis and Aging.42902996 · Zhang, Yinan, Morrow, Sarah A2026 · 0 citationsInternational journal of MS care. 2025;27(Suppl 2):i
The influence of manual dexterity on processing speed assessment in multiple sclerosis: A comparison of the PST and oral SDMT.41110346 · Morrow, Sarah A, Everest, Marina, Beniameen, David et al.2025 · 1 citationMultiple sclerosis and related disorders. 2025;104:106799
2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis.40975102 · Barkhof, Frederik, Reich, Daniel S, Oh, Jiwon et al.2025 · 110 citationsThe Lancet. Neurology. 2025;24(10):866-879
The language and memory test: A brief multidomain digital cognitive measure for multiple sclerosis.40995746 · Leavitt, Victoria M, Simani, Leila, Koch, Marcus et al.2025 · 4 citationsMultiple sclerosis (Houndmills, Basingstoke, England). 2025;31(11):1348-1357
Machine learning using clinical variables to screen for depression and anxiety in people with early multiple sclerosis.40975017 · Phillips, Braxton, Morrow, Sarah A, Singh, Harasees et al.2025 · 3 citationsMultiple sclerosis and related disorders. 2025;104:106761
Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical Trial.40587145 · Silveira, Carolina R A, Coleman, Kristy K L, Borron, Kathy et al.2026 · 26 citationsJAMA neurology. 2025
First-Line Use of Higher-Efficacy Disease-Modifying Therapies in Multiple Sclerosis: Canadian Consensus Recommendations.40485478 · Freedman, Mark S, Clift, Fraser, Devonshire, Virginia et al.2025 · 3 citationsThe Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2025:1-10
Wearing-Off Effect Reports in People With Multiple Sclerosis Receiving Ocrelizumab.42903035 · Morrow, Sarah A, Gitman, Victor, Sofija, Spasojevic et al.2026 · 0 citationsInternational journal of MS care. 2025;27(2):154-162
Addressing patient-reported cognitive impairment in multiple sclerosis clinical practice: A challenging endeavor.40247705 · Macaron, Gabrielle, Farah, Nour, Charbonneau, Simon et al.2025 · 6 citationsMultiple sclerosis (Houndmills, Basingstoke, England). 2025;31(8):896-904
Comparison of vision-related quality of life in NMOSD and MOGAD.40157039 · Gassan, Adnan A, Konig, Andrea, Nisenbaum, Rosane et al.2025 · 4 citationsMultiple sclerosis and related disorders. 2025;97:106392
Does cognitive performance explain the gap between physiological and perceived fall-risk in people with multiple sclerosis?39923414 · Zanotto, Tobia, Pradeep Kumar, Danya, Golan, Daniel et al.2025 · 5 citationsMultiple sclerosis and related disorders. 2025;95:106322
The Language & Memory Test: International feasibility study of an unsupervised digital test of cognition for neurologic populations10.1101/2025.01.28.25321275v1 · Leavitt, V. M., Simani, L., Koch, M. W. et al.2025 · 2 citationsmedRxiv
A retrospective evaluation of patient characteristics and recommendations of a novel multidisciplinary clinic for persons with advanced disability from multiple sclerosis.39864317 · Bateman, Emma A, Gofton, Teneille, Casserly, Courtney et al.2025 · 1 citationMultiple sclerosis and related disorders. 2025;94:106287
New insights into the use of high dose corticosteroids and plasmapheresis in persons with MOGAD and NMOSD.39447245 · Kosior, N, Perrier, R L, Casserly, C et al.2024 · 11 citationsMultiple sclerosis and related disorders. 2024;92:105941
Investigation of health care use and a possible prodrome before the first attack in NMOSD and MOGAD.39234853 · Rotstein, Dalia L, Freedman, Mark S, Konig, Andrea et al.2024 · 4 citationsMultiple sclerosis (Houndmills, Basingstoke, England). 2024;30(10):1331-1340
Monitoring cognitive functioning in multiple sclerosis will trigger anxiety in patients: Commentary.38880941 · Morrow, Sarah A, Hancock, Laura2024 · 1 citationMultiple sclerosis (Houndmills, Basingstoke, England). 2024;30(10):1256-1257
De-escalation of Disease-Modifying Therapy for People with Multiple Sclerosis Due to Safety Considerations: Characterizing 1-Year Outcomes in 25 People Who Switched from Ocrelizumab to Diroximel Fumarate.38861218 · Gudesblatt, Mark, Bumstead, Barbara, Buhse, Marijean et al.2024 · 11 citationsAdvances in therapy. 2024;41(8):3059-3075
Publisher Correction: Summary of Research: What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation.38502463 · Morrow, Sarah A, Kruger, Paola, Langdon, Dawn et al.2024 · 0 citationsNeurology and therapy. 2024;13(3):501
Exploring the relationship between manual dexterity and cognition in people with multiple sclerosis: 9-hole peg and multiple cognitive functions.38850796 · Abraham, Rinu, Waldman-Levi, Amiya, Barrera, Marissa A et al.2024 · 9 citationsMultiple sclerosis and related disorders. 2024;88:105696
Health Canada Drug Approval Process: A Barrier to Personalized Care in Multiple Sclerosis.38777804 · Oh, Jiwon, Bhan, Virender, Traboulsee, Anthony et al.2024 · 0 citationsThe Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2024:1-4
Cognitive impairment and its impact on employment: A qualitative interview-based study involving healthcare professionals and people living with multiple sclerosis.38823313 · Yeandle, David, Morrow, Sarah A, Pontaga, Maija et al.2024 · 6 citationsMultiple sclerosis and related disorders. 2024;87:105631
Self-reported cognitive function mediates the relationship between employment status and cognitive functioning in persons with multiple sclerosis.38761696 · Espiritu, Adrian I, Soliman, Yasmin, Blair, Mervin et al.2024 · 3 citationsMultiple sclerosis and related disorders. 2024;87:105645
Cognitive Impairment in Multiple Sclerosis: Past, Present, and Future.38942528 · Morrow, Sarah A2024 · 10 citationsNeuroimaging clinics of North America. 2024;34(3):469-479
Summary of Research: What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation.38376607 · Morrow, Sarah A, Kruger, Paola, Langdon, Dawn et al.2024 · 1 citationNeurology and therapy. 2024;13(3):497-499
Experiences of people with multiple sclerosis and clinicians in using cognitive behavioural therapies for hidden symptoms: a systematic review and meta-aggregation.38219252 · Feng, Gregory, Posa, Stephanie, Sureshkumar, Ashvene et al.2024 · 13 citationsJournal of neurology. 2024;271(3):1084-1107
Predicting time to serologic diagnosis of AQP4+ NMOSD based on clinical factors and social determinants of health.38242051 · Rotstein, Dalia L, Freedman, Mark S, Lee, Liesly et al.2024 · 11 citationsMultiple sclerosis and related disorders. 2024;83:105434
Response to letter to the editor "Advancing assessment of cognitive change in multiple sclerosis: Seeking valid and sensitive approaches beyond simple cut-offs".38196115 · Morrow, Sarah Anne2024 · 0 citationsMultiple sclerosis (Houndmills, Basingstoke, England). 2024;30(2):278
Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosis.38718640 · Zivadinov, Robert, Bergsland, Niels, Jakimovski, Dejan et al.2024 · 15 citationsNeuroImage. Clinical. 2024;42:103609
Peering further into the mind's eye: combining visual evoked potential and optical coherence tomography measures enhances insight into the variance in cognitive functioning in multiple sclerosis.38091086 · Covey, Thomas J, Golan, Daniel, Sergott, Robert et al.2024 · 4 citationsJournal of neurology. 2024;271(2):658-673
Career total: 244 works. 174 are in this corpus.Showing the 50 most recent.
Profile built from the corpus for this byline.
Author records are still filling in while the Hub is in alpha. If this is your page, you'll be able to claim it soon. Spot a mistake? Tell us.